Mechanisms of Disease: the hypoxic tubular hypothesis of diabetic nephropathy (original) (raw)
Phillips A and Steadman R (2002) Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. Histol Histopathol17: 247–252 CASPubMed Google Scholar
Mogensen CE (1987) Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int31: 673–689 ArticleCASPubMed Google Scholar
Mogensen C et al. (1993) The stages of diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy. Diabetes32 (Suppl 2): S64–S78 Google Scholar
Hasslacher C et al. (1989) Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant4: 859–863 ArticleCASPubMed Google Scholar
Gilbert RE and Cooper ME (1999) The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int56: 1627–1637 ArticleCASPubMed Google Scholar
Brocco E et al. (1997) Renal structure and function in non-insulin dependent diabetic patients with microalbuminuria. Kidney Int63 (Suppl): S40–S44 CAS Google Scholar
Dalla Vestra M et al. (2000) Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab26 (Suppl 4): S8–S14 Google Scholar
Fioretto P et al. (1998) Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia41: 233–236 ArticleCASPubMed Google Scholar
Bohle A et al. (1990) The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract186: 135–144 ArticleCASPubMed Google Scholar
Marcussen N (1992) Atubular glomeruli and the structural basis for chronic renal failure. Lab Invest66: 265–284 CASPubMed Google Scholar
Taft JL et al. (1994) Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Diabetes43: 1046–1051 ArticleCASPubMed Google Scholar
Basturk T et al. (2006) Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination. Ren Fail28: 125–128 ArticleCASPubMed Google Scholar
Catalano C et al. (1993) Effect of posture and acute glycaemic control on the excretion of retinol-binding protein in normoalbuminuric insulin-dependent diabetic patients. Clin Sci (Lond)84: 461–467 ArticleCAS Google Scholar
Ikenaga H et al. (1993) Enzymuria in non-insulin-dependent diabetic patients: signs of tubular cell dysfunction. Clin Sci (Lond)84: 469–475 ArticleCAS Google Scholar
Thomas MC et al. (2006) Functional erythropoietin deficiency in patients with type 2 diabetes and anaemia. Diabet Med23: 502–509 ArticleCASPubMed Google Scholar
Ziyadeh FN (1996) Significance of tubulointerstitial changes in diabetic renal disease. Kidney Int Suppl54: S10–S13 CASPubMed Google Scholar
Jones SC et al. (1999) High glucose increases growth and collagen synthesis in cultured human tubulointerstitial cells. Diabet Med16: 932–938 ArticleCASPubMed Google Scholar
Bleyer AJ et al. (1994) Polyol pathway mediates high glucose-induced collagen synthesis in proximal tubule. Kidney Int45: 659–666 ArticleCASPubMed Google Scholar
Dunlop M (2000) Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl77: S3–S12 ArticleCASPubMed Google Scholar
Harris RC et al. (1986) Sodium-hydrogen exchange and glucose transport in renal microvillus membrane vesicles from rats with diabetes mellitus. J Clin Invest77: 724–733 ArticleCASPubMedPubMed Central Google Scholar
Cooper ME et al. (1997) Diabetic vascular complications. Clin Exp Pharmacol Physiol24: 770–775 ArticleCASPubMed Google Scholar
Cooper ME (1998) Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet352: 213–219 ArticleCASPubMed Google Scholar
Phillips AO et al. (1997) Polarity of stimulation and secretion of transforming growth factor-beta 1 by cultured proximal tubular cells. Am J Pathol150: 1101–1111 CASPubMedPubMed Central Google Scholar
Phillips AO et al. (1996) Induction of TGF-beta 1 synthesis in D-glucose primed human proximal tubular cells by IL-1 beta and TNF alpha. Kidney Int50: 1546–1554 ArticleCASPubMed Google Scholar
Choi YJ et al. (2000) Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol31: 1491–1497 ArticleCASPubMed Google Scholar
Kang D-H et al. (2002) Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol13: 806–816 ArticlePubMed Google Scholar
Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes40: 405–412 ArticleCASPubMed Google Scholar
Salahudeen AK et al. (1997) Pathogenesis of diabetic nephropathy: a radical approach. Nephrol Dial Transplant12: 664–668 ArticleCASPubMed Google Scholar
Schnackenberg CG (2002) Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol282: R335–R342 ArticleCASPubMed Google Scholar
Palm F et al. (2003) Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia46: 1153–1160 ArticleCASPubMed Google Scholar
Palm F et al. (2004) Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-dependent disturbances in rats. Diabetologia47: 1223–1231 ArticleCASPubMed Google Scholar
Buerk DG (2001) Can we model nitric oxide biotransport? A survey of mathematical models for a simple diatomic molecule with surprisingly complex biological activities. Annu Rev Biomed Eng3: 109–143 ArticleCASPubMed Google Scholar
Palm F et al. (2005) Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: effects on renal oxygenation and microcirculation. Diabetes54: 3282–3287 ArticleCASPubMed Google Scholar
Koivisto A et al. (1999) Oxygen-dependent inhibition of respiration in isolated renal tubules by nitric oxide. Kidney Int55: 2368–2375 ArticleCASPubMed Google Scholar
Palm F (2006) Intrarenal oxygen in diabetes and a possible link to diabetic nephropathy. Clin Exp Pharmacol Physiol33: 997–1001 ArticleCASPubMed Google Scholar
Komers R and Anderson S (2003) Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol284: F1121–F1137 ArticleCASPubMed Google Scholar
Mekhail K et al. (2004) HIF activation by pH-dependent nucleolar sequestration of VHL. Nat Cell Biol6: 642–647 ArticleCASPubMed Google Scholar
Higgins DF et al. (2004) Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol287: F1223–F1232 ArticleCASPubMed Google Scholar
Carmeliet P et al. (1998) Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature394: 485–490 ArticleCASPubMed Google Scholar
Manotham K et al. (2004) Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol15: 1277–1288 ArticlePubMed Google Scholar
Norman JT et al. (2000) Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int58: 2351–2366 ArticleCASPubMed Google Scholar
Zhong Z et al. (1998) Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am J Physiol275: F595–F604 CASPubMed Google Scholar
Suga SI et al. (2001) Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity. Am J Physiol Renal Physiol281: F620–F629 ArticleCASPubMed Google Scholar
Vlassara H et al. (1987) Advanced glycation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages: a model for turnover of aging cells. J Exp Med166: 539–549 ArticleCASPubMed Google Scholar
Gutmann FD and Schwartz JC (1990) Pathogenesis of anemia secondary to chronic renal failure. In Erythropoietin in Clinical Applications, 105–140 (Ed Garnick MB) New York: Marcel Dekker Google Scholar
Peterson CM et al. (1977) Reversible hematologic sequelae of diabetes mellitus. Ann Intern Med86: 425–429 ArticleCASPubMed Google Scholar
Jones RL and Peterson CM (1981) Hematologic alterations in diabetes mellitus. Am J Med70: 339–352 ArticleCASPubMed Google Scholar
Kowluru R et al. (1989) Reversible sodium pump defect and swelling in the diabetic rat erythrocyte: effect of filterability and implications for microangiopathy. Proc Natl Acad Sci USA86: 3327–3331 ArticleCASPubMedPubMed Central Google Scholar
Beynon G (1977) The influence of the autonomic nervous system in the control of the erythropoietin secretion in the hypoxic rat. J Physiol266: 347–360 ArticleCASPubMedPubMed Central Google Scholar
Spannhake EWM and Fisher JW (1977) Partial inhibition of hypoxia-induced erythropoietin production by cholinergic blockade in the dog. Proc Soc Exp Biol Med156: 19–23 ArticleCASPubMed Google Scholar
Biaggioni I et al. (1994) The anemia of primary autonomic failure and its reversal with erythropoietin. Ann Intern Med121: 181–186 ArticleCASPubMed Google Scholar
Fink GD and Fisher JW (1977) Stimulation of erythropoiesis by β adrenergic agonists. II. Mechanisms of action. J Pharmacol Exp Ther202: 199–208 CASPubMed Google Scholar
Zivny J et al. (1983) Effect of β adrenergic blocking agents on erythropoiesis in rats. J Pharmacol Exp Ther226: 222–225 CASPubMed Google Scholar
Testa I et al. (1988) Abnormal membrane fluidity and acetyl cholinesterase activity in erythrocytes from insulin-dependent diabetic patients. J Clin Endocrinol Metab67: 1129–1133 ArticleCASPubMed Google Scholar
Bosman DR et al. (2001) Anaemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care24: 495–499 ArticleCASPubMed Google Scholar
Thomas MC et al. (2003) Unrecognized anemia in patients with diabetes: a cross-sectional survey. Diabetes Care26: 1164–1169 ArticlePubMed Google Scholar
Fioretto P et al. (1996) Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia39: 1569–1576 ArticleCASPubMed Google Scholar
Winkler AS et al. (1999) Erythropoietin depletion and anaemia in diabetes mellitus. Diabet Med16: 813–819 ArticleCASPubMed Google Scholar
Bosman DR et al. (2002) Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure. Diabet Med19: 65–69 ArticleCASPubMed Google Scholar
Capla JM et al. (2007) Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. Plast Reconstr Surg119: 59–70 ArticleCASPubMed Google Scholar
Katavetin P et al. (2006) High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor/hypoxia-responsible element pathway. J Am Soc Nephrol17: 1405–1413 ArticleCASPubMed Google Scholar
Kunika K et al. (1997) Damage of charge-dependent renal tubular reabsorption causes diabetic microproteinuria. Diab Res Clin Pract36: 1–9 ArticleCAS Google Scholar
Yaqoob M et al. (1994) Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis. Kidney Int Suppl47: S101–S104 CASPubMed Google Scholar
Yaqoob M et al. (1993) Relationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin-dependent diabetes mellitus. Clin Sci (Lond)85: 557–562 ArticleCAS Google Scholar
Yaqoob M et al. (1994) Evidence of oxidant injury and tubular damage in early diabetic nephropathy. QJM87: 601–607 CASPubMed Google Scholar
Thomson SC et al. (2004) Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol286: F8–F15 ArticleCAS Google Scholar
Evangelista C et al. (2006) Glomerulo-tubular balance in diabetes mellitus: molecular evidence and clinical consequences. G Ital Nefrol23 (Suppl 34): S16–S20 PubMed Google Scholar
Vallon V et al. (2003) Glomerular hyperfiltration and the salt paradox in early [corrected] type 1 diabetes mellitus: a tubulo-centric view. J Am Soc Nephrol14: 530–537 ArticlePubMed Google Scholar
Ditzel J et al. (1989) Renal sodium metabolism in relation to hypertension in diabetes. Diabete Metab15: 292–295 CASPubMed Google Scholar
Quinones-Galvan A and Ferrannini E (1997) Renal effects of insulin in man. J Nephrol10: 188–191 CASPubMed Google Scholar
Vervoort G et al. (2005) Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Eur J Clin Invest35: 330–336 ArticleCASPubMed Google Scholar
Mahnensmith RL and Aronson PS (1985) Interrelationships among quinidine, amiloride, and lithium as inhibitors of the renal Na+-H+ exchanger. J Biol Chem260: 12586–12592 CASPubMed Google Scholar
Krolewski AS et al. (1988) Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med318: 140–145 ArticleCASPubMed Google Scholar
Pedersen SB et al. (1993) Inhibition of renal ornithine decarboxylase activity prevents kidney hypertrophy in experimental diabetes. Am J Physiol Cell Physiol264: C453–C456 ArticleCAS Google Scholar
Tian J (2007) Potential role of active vitamin D in retarding the progression of chronic kidney disease. Nephrol Dial Transplant22: 321–328 ArticlePubMed Google Scholar
Levin A et al. (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int71: 31–38 ArticleCASPubMed Google Scholar
Wang Y (2006) Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy. Kidney Int70: 882–891 ArticlePubMedCAS Google Scholar
Feldman D et al. (2005) Vitamin D, edn 2. London: Elsevier Academic Press Google Scholar
Weinreich T et al. (1991) Actions of 1,25-dihydroxyvitamin D3 on human mesangial cells. Am J Kidney Dis18: 359–366 ArticleCASPubMed Google Scholar
Weinreich T et al. (1996) 1,25-Dihydroxyvitamin D3 and the synthetic vitamin D analogue, KH 1060, modulate the growth of mouse proximal tubular cells. Kidney Blood Press Res19: 325–331 ArticleCASPubMed Google Scholar
Panichi V et al. (2001) Effects of 1,25 (OH)2D3 in experimental mesangial proliferative nephritis in rats. Kidney Int60: 87–95 ArticleCASPubMed Google Scholar
Li YC et al. (2002) 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest110: 229–238 ArticleCASPubMedPubMed Central Google Scholar
Xiang W et al. (2005) Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin–angiotensin systems. Am J Physiol Endocrinol Metab288: E125–E132 ArticleCASPubMed Google Scholar
Fine LG et al. (1998) Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int Suppl65: S74–S78 CASPubMed Google Scholar
Fine LG et al. (2000) Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int Suppl75: S22–S26 ArticleCASPubMed Google Scholar
Kang DH et al. (2002) Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol13: 806–816 ArticlePubMed Google Scholar
Eckardt KU et al. (2003) Role of hypoxia in the pathogenesis of renal disease. Blood Purif21: 253–257 ArticlePubMed Google Scholar
Nangaku M (2004) Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. Nephron Exp Nephrol98: e8–e12 ArticlePubMed Google Scholar
Bunn HF and Poynton R (1996) Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev76: 839–885 ArticleCASPubMed Google Scholar
Shih S-C and Claffey KP (1998) Hypoxia regulation of gene expression in mammalian cells. Int J Exp Pathol70: 347–357 Google Scholar
Ratcliffe PJ et al. (1998) Oxygen sensing, hypoxia-inducible factor 1 and the regulation of gene expression. J Exp Biol201: 1153–1162 CASPubMed Google Scholar
Nangaku M (2006) Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol17: 17–25 ArticleCASPubMed Google Scholar
Futrakul N et al. (2005) Tubular dysfunction and hemodynamic alteration in normoalbuminuric type 2 diabetes. Clin Hemorheol Microcirc32: 59–65 CASPubMed Google Scholar
Allen DA et al. (2003) High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J17: 908–910 ArticleCASPubMed Google Scholar
Verzola D et al. (2004) Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells J Am Soc Nephrol15: S85–S87 ArticleCASPubMed Google Scholar
Jelkmann W (2002) The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP. Eur J Haematol69: 265–274 ArticleCASPubMed Google Scholar
Stohlman F Jr and Brecher G (1959) Humoral regulation of erythropoiesis. V. Relationship of plasma erythropoietin level to bone marrow activity. Proc Natl Acad Sci USA100: 40–43 CAS Google Scholar
Gross AW and Lodish HF (2006) Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP). J Biol Chem281: 2024–2032 ArticleCASPubMed Google Scholar
Veng-Pedersen P et al. (1995) Kinetic evaluation of nonlinear drug elimination by a disposition decomposition analysis: application to the analysis of the nonlinear elimination kinetics of erythropoietin in adult humans. J Pharm Sci84: 760–767 ArticleCASPubMed Google Scholar
Veng-Pedersen P et al. (1999) A comparison of nonlinear pharmacokinetics of erythropoietin in sheep and humans. Biopharm Drug Dispos20: 217–223 ArticleCASPubMed Google Scholar
Yoon WH et al. (1997) Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats. Res Commun Mol Pathol Pharmacol96: 227–240 CASPubMed Google Scholar
Chapel SH et al. (2001) Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokinetics. Exp Hematol29: 425–431 ArticleCASPubMed Google Scholar
Symeonidis A et al. (2006) Inappropriately low erythropoietin response for the degree of anemia in patients with noninsulin-dependent diabetes mellitus. Ann Hematol85: 79–85 ArticleCASPubMed Google Scholar
Thomas MC et al. (2006) Functional erythropoietin deficiency in patients with Type 2 diabetes and anaemia. Diabet Med23: 502–509 ArticleCASPubMed Google Scholar
Craig KJ et al. (2005) Anemia and diabetes in the absence of nephropathy. Diabetes Care28: 1118–1123 ArticlePubMed Google Scholar
Laffont I et al. (2002) Early-glycation of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates. Biochim Biophys Acta1583: 99–107 ArticleCASPubMed Google Scholar
Dikow R et al. (2002) How should we manage anaemia in patients with diabetes? Nephrol Dial Transplant17 (Suppl 1): S67–S72 Article Google Scholar
Kaysen GA (2001) The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol12: 1549–1557 CASPubMed Google Scholar
Goicoechea M et al. (1998) Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int54: 1337–1343 ArticleCASPubMed Google Scholar
Zanjani ED et al. (1982) In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection. Br J Haematol50: 479–490 ArticleCASPubMed Google Scholar
Zhang Z et al. (2008) Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int73: 163–171 ArticleCASPubMed Google Scholar
Nishizawa Y and Shoji T (2006) Does paricalcitol reduce proteinuria in patients with chronic kidney disease? Nat Clin Pract Nephrol2: 352–353 ArticlePubMed Google Scholar
Vogel V et al. (1997) Effects of erythropoietin on endothelin-1 synthesis and the cellular calcium messenger system in vascular endothelial cells. Am J Hypertens10: 289–296 ArticleCASPubMed Google Scholar
Anagnostou A et al. (1990) Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad SciUSA87: 5978–5982 ArticleCAS Google Scholar
Carlini RG et al. (1993) Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int43: 1010–1014 ArticleCASPubMed Google Scholar
Carlini RG et al. (1995) Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int47: 740–745 ArticleCASPubMed Google Scholar
Gouva C et al. (2004) Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int66: 753–760 ArticlePubMed Google Scholar
Garcia DL et al. (1988) Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. Proc Natl Acad Sci USA85: 6142–6146 ArticleCASPubMedPubMed Central Google Scholar
Besarab A et al. (1998) The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med339: 584–590 ArticleCASPubMed Google Scholar
Singh AK et al. for the CHOIR Investigators (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med355: 2085–2098 ArticleCASPubMed Google Scholar
Begg C et al. (1996) Improving the quality of reporting of randomized trials: the CONSORT statement. JAMA276: 637–639 ArticleCASPubMed Google Scholar
Drueke TB et al. for the CREATE Investigators (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med355: 2071–2084 ArticleCASPubMed Google Scholar
Lappin TR et al. (2002) EPO's alter ego: erythropoietin has multiple actions. Stem Cells20: 485–492 ArticleCASPubMed Google Scholar
Sasaki R et al. (2001) Pleiotropic functions and tissue-specific expression of erythropoietin. News Physiol Sci16: 110–113 CASPubMed Google Scholar
Lee SH et al. (2005) Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy. Am J Nephrol25: 64–76 ArticleCASPubMed Google Scholar
Chong ZZ et al. (2002) Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation106: 2973–2979 ArticleCASPubMed Google Scholar
Cerami A et al. (2002) Neuroprotective properties of epoetin alfa. Nephrol Dial Transplant17 (Suppl 1): S8–S12 Article Google Scholar
Heeschen C et al. (2003) Erythropoietin is a potent physiological stimulus for endothelial progenitor cell mobilization. Blood102: 1340–1346 ArticleCASPubMed Google Scholar
Calvillo L et al. (2003) Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA100: 4802–4806 ArticleCASPubMedPubMed Central Google Scholar
Spandou E et al. (2006) Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant21: 330–336 ArticleCASPubMed Google Scholar
Fliser D et al. (2006) EPO: renoprotection beyond anemia correction. Pediatr Nephrol21: 1785–1789 ArticlePubMed Google Scholar
Sharples EJ and Yaqoob MM (2006) Erythropoietin and acute renal failure. Semin Nephrol26: 325–331 ArticleCASPubMed Google Scholar
Mitra A et al. (2007) Erythropoietin ameliorates renal dysfunction during endotoxaemia. Nephrol Dial Transplant22: 2349–2353 ArticleCASPubMed Google Scholar
Sharples EJ et al. (2004) Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol15: 2240–2241 ArticleCAS Google Scholar
Youssoufian H et al. (1993) Structure, function, and activation of the erythropoietin receptor. Blood81: 2223–2236 CASPubMed Google Scholar
Westenfelder C et al. (1999) Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int55: 808–820 ArticleCASPubMed Google Scholar
Lacombe C et al. (1988) Peritubular cells are the site of erythropoietin synthesis in the murine hypoxia kidney. J Clin Invest81: 620–623 ArticleCASPubMedPubMed Central Google Scholar
Koury S et al. (1988) Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood71: 524–527 CASPubMed Google Scholar
Bachmann S et al. (1993) Colocalization of erythropoietin messenger RNA and ecto-5'-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem41: 335–341 ArticleCASPubMed Google Scholar
Maxwell P et al. (1993) Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int44: 1149–1162 ArticleCASPubMed Google Scholar
Eckardt KU et al. (1993) Distribution of erythropoietin producing cells in rat kidneys during hypoxic hypoxia. Kidney Int43: 815–823 ArticleCASPubMed Google Scholar
Brines M and Cerami A (2006) Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney Int70: 246–250 ArticleCASPubMed Google Scholar
Sharples EJ and Yaqoob MM (2006) Erythropoietin in experimental acute renal failure. Nephron Exp Nephrol104: e83–e88 ArticleCASPubMed Google Scholar
Johnson DW et al. (2006) Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int69: 1806–1813 ArticleCASPubMed Google Scholar
Johnson DW et al. (2006) Novel renoprotective actions of erythropoietin: new uses for an old hormone. Nephrology (Carlton)11: 306–312 ArticleCAS Google Scholar
Vesey DA et al. (2004) Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant19: 348–355 ArticleCASPubMed Google Scholar
Bahlmann FH et al. (2004) Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation110: 1006–1012 ArticleCASPubMed Google Scholar